Ryan Zackon, Hairmax CEO
Hairmax CEO Ryan Zackon Embarks on a Global Journey to Connect with Employees and Stakeholders
11 août 2023 08h59 HE | Hairmax
BOCA RATON, Fla., Aug. 11, 2023 (GLOBE NEWSWIRE) -- Hairmax, the pioneer and global leader in transformative hair growth, announced today that CEO Ryan Zackon has embarked on a 4-week, 22-city trip...
hairmax-icon-black+V2.jpg
Hairmax Offers Hair Growth & Wellness Guide During Hair Loss Awareness Month
03 août 2023 08h59 HE | Hairmax
BOCA RATON, Fla., Aug. 03, 2023 (GLOBE NEWSWIRE) -- August is recognized as National Hair Loss Awareness Month, a time to bring attention to an issue that affects a significant number of people at...
hairmax-icon-black+V2.jpg
Hairmax Featured on National TV Morning Show, Generates Over $275,000 in Revenue
28 juin 2023 08h59 HE | Hairmax
BOCA RATON, Fla., June 28, 2023 (GLOBE NEWSWIRE) -- On June 15th, Hairmax, the leader in transformative hair regrowth, was featured on one of the highest ranking syndicated, morning television shows...
TH_logo_couleur.png
Triple Hair Group reçoit l'approbation de Santé Canada pour commencer les essais cliniques de phase III sur son médicament sur ordonnance Thérapie-07 au Canada
28 juin 2023 07h00 HE | Triple Hair Inc.
MONTRÉAL, 28 juin 2023 (GLOBE NEWSWIRE) -- Triple Hair Group Inc. (« Triple Hair » ou la « Société »), un leader mondial dans le développement de traitements novateurs contre l'alopécie, a le...
TH_logo_couleur.png
Triple Hair Group receives Health Canada approval to start Phase III clinical trials on its Therapy-07 prescription drug in Canada
28 juin 2023 07h00 HE | Triple Hair Inc.
MONTRÉAL, June 28, 2023 (GLOBE NEWSWIRE) -- Triple Hair Group Inc. (“Triple Hair” or the “Company”), a global leader in the development of innovative treatments for alopecia, is pleased to...
TH_logo_couleur.png
Triple Hair Group consolide sa position d’innovateur et de leader d'industrie pour son médicament sur ordonnance Thérapie-07 aux États-Unis
19 juin 2023 07h00 HE | Triple Hair Inc.
La Société renforce la protection de sa propriété intellectuelle dans le plus grand marché mondial.Cette protection additionnelle permettra de réduire le risque de contrefaçon de son produit phare et...
TH_logo_couleur.png
Triple Hair Group consolidates its position as industry leader and innovator for its Therapy-07 prescription drug in the U.S.
19 juin 2023 07h00 HE | Triple Hair Inc.
The Company strengthens the protection of its intellectual property in the world's largest marketThe additional protection will reduce the risk of infringement of its flagship product, thereby...
Ryan F. Zackon, Hairmax CEO
Hairmax Appoints Ryan F. Zackon as Chief Executive Officer
14 juin 2023 08h59 HE | Hairmax
BOCA RATON, Fla., June 14, 2023 (GLOBE NEWSWIRE) -- Hairmax, the pioneer and global leader in transformative hair regrowth, announced today that it has appointed Ryan F. Zackon as its Chief...
TH_logo_couleur.png
Triple Hair Group annonce des résultats positifs des études d’innocuité sur son médicament sur ordonnance Thérapie-07
14 juin 2023 07h00 HE | Triple Hair Inc.
MONTRÉAL, 14 juin 2023 (GLOBE NEWSWIRE) -- Triple Hair Group Inc. (« Triple Hair » ou la « Société »), une société spécialisée dans le développement de traitements novateurs contre l’alopécie,...
TH_logo_couleur.png
Triple Hair Group Reports Positive Results from Safety Studies on its Therapy-07 Prescription Drug
14 juin 2023 07h00 HE | Triple Hair Inc.
MONTRÉAL, June 14, 2023 (GLOBE NEWSWIRE) -- Triple Hair Group Inc. (“Triple Hair” or the “Company”), a company specializing in the development of innovative treatments for alopecia, is pleased...